Daniel Virnich

Daniel Virnich

atStarling Oncology· In proxies 2022–2025

Pay in FY2025+73% from the year before · Starling Oncology stock +1,052.1% the same year

Daniel Virnich was paid $1.9M in FY2025 (Dec), up 73%. Starling Oncology stock rose 1,052.1% that year.

Pay$100 in the stock at the end of FY21 → $37
Pay is from the Summary Compensation Table of each Starling Oncology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Starling OncologyPublic company · 4 yr
    • 2022 – Present · 4 yrStock in role -39%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?